UCP1 and obesity due to melanocortin 4 receptor deficiency: This is in part due to the overwhelming evidence that activation of β3-ARs leading to increased UCP1 expression and function in BAT can reverse obesity, and prevent the development of insulin resistance and diabetes in rodents (42–45).